Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ELI LILLY AND COMPANY

(LLY)
  Report
Delayed Nyse  -  04:03 2022-12-09 pm EST
360.99 USD   -2.90%
09:23aUBS Adjusts Eli Lilly and Company Price Target to $428 From $407, Maintains Buy Rating
MT
08:26aEli Lilly Ends Insulin Pump Project With Ypsomed
MT
04:02aEli Lilly Abandons Insulin Pump Joint Venture With Ypsomed To Focus On Drug Portfolio
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Eli Lilly and Company
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (46.6%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (20.3%);

- immunology diseases (11.8%);

- neurology (6.7%): primarily drugs used in treating depression and schizophrenia;

- other (14.6%).

Net sales are distributed geographically as follows: the United States (59.4%), Europe (16.9%), Japan (8.3%), China (5.9%) and other (9.5%).

Number of employees : 35 000 people.
Sales per Business
20202021Delta
Pharmaceutical Products24 539.80100%28 318.40100% +15.4%
USD in Million
Sales per region
20202021Delta
United States14 229.3058%16 811.0059.4% +18.14%
Europe4 187.7017.1%4 776.8016.9% +14.07%
Other Foreign Countries2 422.709.9%2 702.209.5% +11.54%
Japan2 583.1010.5%2 367.008.4% -8.37%
China1 116.904.6%1 661.405.9% +48.75%
USD in Million
Managers
Name Title Age Since
David Ricks Chairman, President & Chief Executive Officer 53 2017
Anat Ashkenazi Chief Financial Officer & Senior Vice President 48 2021
Daniel Skovronsky Chief Scientific Officer & Senior Vice President 47 -
Diogo Rau Senior VP, Chief Information & Digital Officer - 2021
Alonzo Weems Senior VP, Chief Ethics & Compliance Officer - 2021
Kevin Hern Investor Relations Contact - -
Anat Hakim Secretary, Senior Vice President & General Counsel 51 -
Anne E. White Senior Vice President 52 2018
Nathaniel R. Miles Vice President-Strategic Initiatives - 2012
Robert J. Heine, Dr. Vice President-Medical Affairs - 2009
Members of the board
Name Title Age Since
David Ricks Chairman, President & Chief Executive Officer 53 2017
Jon Erik Fyrwald Independent Director 63 2005
Ralph Alvarez Independent Director 66 2009
Katherine Baicker, Dr. Independent Director 49 2011
William G. Kaelin, Dr. Independent Director 63 2012
Marschall S. Runge, Dr. Independent Director 66 2013
Jackson Peter Tai Independent Director 69 2013
Juan Luciano Lead Independent Director 59 2019
Jamere Jackson Independent Director 51 2016
Karen Walker Independent Director 59 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 950,627,900 948,746,136 99.8% 450,000 0.0% 99.8%
Shareholders
NameEquities%
Capital Research & Management Co. 109,033,091 11.5%
Lilly Endowment, Inc. 103,773,810 10.9%
The Vanguard Group, Inc. 69,272,517 7.29%
PNC Bank, NA (Investment Management) 52,025,452 5.48%
SSgA Funds Management, Inc. 33,582,472 3.53%
Capital Research & Management Co. (World Investors) 29,024,874 3.05%
PRIMECAP Management Co. 28,017,155 2.95%
Fidelity Management & Research Co. LLC 26,985,679 2.84%
T. Rowe Price Associates, Inc. (Investment Management) 24,839,322 2.61%
Wellington Management Co. LLP 21,843,288 2.30%
Holdings
NameEquities%Valuation
IMMUNOCORE HOLDINGS PLC 2,548,145 6.25% 145,601,005 USD
DIZAL JIANGSU PHARMACEUTICAL CO. LTD. 17,895,349 4.90% 94,103,409 USD
CANSINO BIOLOGICS INC. (688185) 1,546,071 2.31% 40,173,774 USD
SHENZHEN YHLO BIOTECH CO., LTD. (688575) 12,740,000 4.96% 34,718,793 USD
AVIDITY BIOSCIENCES, INC. (RNA) 2,319,396 4.45% 33,120,975 USD
ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (603229) 5,644,800 1.42% 20,224,641 USD
MICROTECH MEDICAL (HANGZHOU) CO., LTD. 21,776,804 7.60% 16,894,662 USD
PEIJIA MEDICAL LIMITED (9996) 19,952,740 2.95% 16,521,667 USD
NEXTCURE, INC. (NXTC) 1,704,391 6.14% 4,260,978 USD
PROQR THERAPEUTICS N.V. (PRQR) 3,989,976 5.60% 3,690,728 USD
Markets and indexes
- International Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  LILY11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Eli Lilly and Company
Lilly Corporate Center
IN 46285 Indianapolis, Indiana

Phone : +1 617-225-3226
Fax :
web site : https://investor.lilly.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eli Lilly and Company
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ELI LILLY AND COMPANY34.66%353 267
JOHNSON & JOHNSON3.57%463 286
ABBVIE INC.22.59%293 450
PFIZER, INC.-14.92%290 657
NOVO NORDISK A/S22.08%287 434
MERCK & CO., INC.44.64%281 049
ROCHE HOLDING AG-20.09%267 313
ASTRAZENECA PLC30.40%214 308
NOVARTIS AG6.25%196 152
BRISTOL-MYERS SQUIBB COMPANY28.20%177 305
AMGEN INC.27.02%152 374
SANOFI0.47%117 709
GILEAD SCIENCES, INC.20.91%112 217
GSK PLC-9.73%73 637
DAIICHI SANKYO CO., LTD.50.97%61 981
BAYER AG12.19%54 633
TAKEDA PHARMACEUTICAL COMPANY LIMITED28.12%45 745
CHUGAI PHARMACEUTICAL CO., LTD-3.43%43 443
JIANGSU HENGRUI MEDICINE CO., LTD.-23.45%35 592
ASTELLAS PHARMA INC.13.61%28 357
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-37.55%23 286